Drag a card by its title · ⚙ to size, swap or remove

The company

Outlook Therapeutics, Inc.

OTLK · Nasdaq

Health CareBiotechnologyNot moving yet

OTLK stood above a rising 150-day average in 6 of the last 52 weekly readings, and has been out of that trend for the last 42 weeks. It is 33.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 42
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $15.8M
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 68 (+19)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 6 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months11

Sale orders, 12 months0

Buyers · sellers8 · 0

Who	Did	Shares	Traded
Robert Charles JahrChief Executive Officer	bought	151,515	14 Aug 2026filed 14 Aug 2026
Robert Charles JahrChief Executive Officer	bought	151,515	14 Aug 2026filed 14 Aug 2026
Lawrence A. KenyonChief Financial Officer	bought	101,010	14 Aug 2026filed 14 Aug 2026
Lawrence A. KenyonChief Financial Officer	bought	101,010	14 Aug 2026filed 14 Aug 2026
Ghiath M. SukhtianDirector, 10% owner	bought	2,525,252at $0.99	12 Aug 2026filed 14 Aug 2026
Ghiath M. SukhtianDirector, 10% owner	bought	2,525,252at $0.00	12 Aug 2026filed 14 Aug 2026
Faisal Ghiath SukhtianDirector	bought	95,398at $1.05	29 Jul 2026filed 29 Jul 2026
Yezan Munther HaddadinDirector	bought	29,000at $0.8326	2 Jun 2026filed 3 Jun 2026
Ghiath M. SukhtianDirector, 10% owner	bought	8,539,709at $0.5855	28 May 2026filed 1 Jun 2026
Ghiath M. SukhtianDirector, 10% owner	bought	3,458,571	28 May 2026filed 1 Jun 2026
Ghiath M. SukhtianDirector, 10% owner	bought	3,458,571	28 May 2026filed 1 Jun 2026
Ghiath M. SukhtianDirector, 10% owner	bought	8,571,428	28 May 2026filed 1 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders68+19 on the quarter

New · exited30 · 12

Reported value$30.9M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	4,376,872$7.0M	+2,409,712+122.5%
PERCEPTIVE ADVISORS LLCnew · filed 14 Aug 2026	3,139,216$5.0M	+3,139,216
MARSHALL WACE, LLPnew · filed 13 Aug 2026	1,987,578$3.2M	+1,987,578
BlackRock, Inc.added · filed 7 Aug 2026	1,668,579$2.7M	+1,191,108+249.5%
JANE STREET GROUP, LLCnew · filed 14 Aug 2026	1,425,270$2.3M	+1,425,270
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	1,245,868$2.0M	+642,262+106.4%
SUSQUEHANNA INTERNATIONAL GROUP, LLPadded · filed 14 Aug 2026	968,190$1.5M	+834,106+622.1%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026	661,664$1.1M	+485,135+274.8%
GILPIN WEALTH MANAGEMENT, LLCreduced · filed 24 Jul 2026	555,000$882K	-45,162−7.5%
STATE STREET CORPadded · filed 7 Aug 2026	539,802$858K	+376,700+231.0%